# US 2020/0393408 A1 · Allergy antigen and epitope thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0393408 A1
- Document ID: US20200393408A1
- Status: Published application
- Kind: A1
- Application number: 16/899,643
- Filed: 2020-06-12
- Published: 2020-12-17
- Earliest claimed: 2019-06-13
- Assignees: Hoyu Co., Ltd.
- Applicants: Hoyu Co., Ltd.
- Inventors: Kayoko Matsunaga; Akiko Yagami; Yuji Aoki; Erika Hasegawa; Tomomi Sakai
- Web page: https://patentgrep.com/patent/US20200393408A1

## CPC

- A61P 37/08: Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14)
- G01N 27/44778: {on a common gel carrier, i.e. 2D gel electrophoresis}
- A61K 39/35: Allergens
- C07K 1/285: {multi dimensional electrophoresis}
- C07K 14/415: from plants
- G01N 33/6854: {Immunoglobulins}
- G01N 33/6893: {related to diseases not provided for elsewhere}
- A61K 2039/542: {oral/gastrointestinal}
- A61K 2039/577: {tolerising response}
- G01N 2800/24: Immunology or allergic disorders
- G01N 2800/245: Transplantation related diseases, e.g. graft versus host disease
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention provides novel antigens of an allergy to wheat, methods and kits for diagnosing an allergy to wheat, compositions comprising such an antigen, wheat or processed products of wheat in which such an antigen is eliminated, and a tester composition for determining the presence or absence of a wheat antigen in an object of interest. The present invention also relates to polypeptides comprising an epitope of an antigen, kits, compositions and methods for diagnosing an allergy, comprising such a polypeptide, compositions comprising such a polypeptide, and raw materials or processed products in which an antigen comprising such a polypeptide is eliminated or reduced. The present invention further relates to a tester composition for determining the presence or absence of an antigen in an object of interest.

## Claims

### Claim 1

A kit for diagnosing an allergy, comprising at least one of the following polypeptides (E1) to (E50):
(E1) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 29-130 and 2880;
(E2) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 131-137 and 139-190;
(E3) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 191-280 (except for 227, 259, 269 and 273) and 2881;
(E4) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 281-341 and 343-345;
(E5) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 346-398, 400-413 and 2882;
(E6) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 414-492, 2883 and 2884;
(E7) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 493-561;
(E8) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 562-639;
(E9) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 640-705 and 2885-2888;
(E10) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 706-775 and 2889-2891;
(E11) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 776-898 and 2892;
(E12) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 899-973, 2893 and 2895;
(E13) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 974-1009;
(E14) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 1010-1088 and 2896-2899;
(E15) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 1089-1141;
(E16) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 1142-1165 and 2900;
(E17) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 1166-1208;
(E18) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 1209-1256;
(E19) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 1257-1296;
(E20) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 1297-1366;
(E21) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 1367-1402;
(E22) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 1403-1507;
(E23) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 1508-1565 and 2901;
(E24) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 1566-1597;
(E25) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 1598-1607;
(E26) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 1608-1684, 2902 and 2903;
(E27) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 1685-1752, 2904 and 2905;
(E28) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 1753-1788, 2906 and 2907;
(E29) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 1789-1835, 2908 and 2909;
(E30) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 1836-1894, 2910 and 2911;
(E31) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 1895-1976, 2912 and 2913;
(E32) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 1977-2003;
(E33) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 2004-2026;
(E34) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 2027-2067 and 2914;
(E35) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 2068-2153, 2915 and 2916;
(E36) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 2154-2216;
(E37) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 2217-2264 and 2917-2921;
(E38) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 2265-2308 and 2922-2925;
(E39) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 2309-2341;
(E40) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 2342-2418;
(E41) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 2419-2490;
(E42) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 2491-2544, 2926 and 2927;
(E43) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 2545-2612;
(E44) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 2613-2630;
(E45) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 2631-2673;
(E46) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 2674-2700 and 2928;
(E47) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 2701-2773 and 2929;
(E48) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 2774-2808, 2930 and 2931;
(E49) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 2809-2829; and
(E50) a polypeptide comprising at least one amino acid sequence selected from the amino acid sequences of SEQ ID NOs: 2830-2879 and 2932.

### Claim 2 (depends on 1)

A composition for diagnosing an allergy, the composition comprising at least one of polypeptides (E1) to (E50) according to claim 1.

### Claim 3 (depends on 1)

A method for providing an indicator for diagnosing an allergy in a subject, the method comprising the steps of:
(i) contacting a sample obtained from the subject with an antigen, wherein the sample is a solution comprising an IgE antibody;
(ii) detecting binding between the IgE antibody present in the sample obtained from the subject and the antigen; and
(iii) when the binding between the IgE antibody in the subject and the antigen is detected, an indicator of the fact that the subject is allergic is provided;
wherein the antigen is at least one of polypeptides (E1) to (E50) according to claim 1.

### Claim 4 (depends on 1)

An antigen which is at least one of polypeptides (E1) to (E50) according to claim 1 and is causative of an allergy.

### Claim 5 (depends on 4)

A composition comprising at least one antigen according to claim 4.

### Claim 6 (depends on 5)

The composition according to claim 5, wherein the composition is intended for the treatment of an allergy.

### Claim 7 (depends on 1)

A tester composition for determining the presence or absence of an antigen in a subject, the tester composition comprising an antibody that binds to at least one of polypeptides (E1) to (E50) according to claim 1.

### Claim 8 (depends on 1)

A tester composition for determining the presence or absence of an antigen in an object of interest, the tester composition comprising at least one primer comprising a portion of the nucleotide sequence of a nucleic acid encoding any of polypeptides (E1) to (E50) according to claim 1, and/or a portion of a complementary strand thereof.

### Claim 9 (depends on 1)

A tester composition for determining the presence or absence of an IgE antibody in a subject, the tester composition comprising polypeptides (E1) to (E50) according to claim 1.

### Claim 10 (depends on 1)

A method for determining the presence or absence of polypeptides (E1) to (E50) according to claim 1 in a raw material or a processed product, comprising detecting the polypeptides (E1) to (E50) according to claim 1 in the raw material or the processed product.

### Claim 11 (depends on 1)

A raw material or a processed product in which an antigen is eliminated or reduced, wherein the antigen is at least one of polypeptides (E1) to (E50) according to claim 1.

### Claim 12 (depends on 1)

A method for producing a raw material or a processed product in which an antigen is eliminated or reduced, the method comprising the step of confirming that the antigen is eliminated or reduced, in a production process of the processed product, wherein the antigen is at least one of polypeptides (E1) to (E50) according to claim 1.
